|
Breast Tumor Targeted Fluorescence Guidance for Intraoperative Margin Assessment
This technology is an anti-CEACAM6 antibody tagged with fluorescent labels. The idea is that these fluorescent antibodies can be used for real-time molecular fluorescence imaging to help guide the surgical removal of a tumor. This technology is targeted toward breast cancer.
Background:
Over half of the 270,000 breast cancer diagnoses in the United...
Published: 6/24/2024
|
Updated: 5/7/2020
|
Inventor(s): Daruka Mahadevan, David Morse, Marie Catherine Lee, Narges Tafreshi
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Oncology
|
